HealthCareAisle Naproxen Sodium, 220 mg - 225 caplets - Headache Pain Reliever, Up to 12 Hours of Relief
- Naproxen Sodium caplets temporarily relieve minor aches and pains due to: headache, minor pain of arthritis, muscular aches, backache, menstrual cramps, toothache, the common cold; also temporarily reduces fever
- Comparable to the national brand: Has the same active ingredient as Aleve Headache Pain Caplets*
- Effective pain and fever relief for up to 12 hours
- See package label for warnings, directions and other important information; use only as directed; HSA or FSA Eligible
Pain relief medicine: Naproxen Sodium caplets is an over-the-counter nonsteroidal anti-inflammatory drug (NSAID) that can provide temporary relief of headache pain
Información importante
Ingredientes
Naproxen sodium USP, 220 mg (naproxen USP, 200 mg) (NSAID)*... Pain reliever/fever reducer *nonsteroidal anti-inflammatory drug, FD &C Blue # 2, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, povidone, talc, titanium dioxide
Legal Disclaimer
As declaracións sobre suplementos dietéticos non foron avaliadas pola FDA e non están destinadas a diagnosticar, tratar, curar ou previr ningunha enfermidade ou condición de saúde.
Dimensións do produto
2.1 x 2.1 x 3.6 inches; 3.17 ounces
Specifications
| Ingredientes | Hipromellose, Dióxido de titanio, Talc, Estilado de magnesio, celulosa microcristalina, Povidone, Polisorbado 80, Polietileno Glycol, Naproxen Sodium Usp, 220 Mg (naproxen Usp), 200 Mg) (nsaid)* ... Reliever/fever Reducer * drogo antiinflamatorio non esteroideo, Fd&c Blue 2 |
| Data de caducidade | Xullo 2027 |
| Beneficios do produto | Ax |
| Dimensións L X W X H | 2.1 X 2.1.3 Inches |
| Usos específicos do produto | Cw |
| Ingredientes activos | Bq |
| Brand | Asistencia Sanitaria |
| Tipo de produto | medicación |
| Tags | |
|---|---|
| Tags | |
Your Dynamic Snippet will be displayed here...
This message is displayed because youy did not provide both a filter and a template to use.









